To assess the cytotoxic efficacy of B7-H3-specific CAR T cells against GBM cells, we co-cultured three GBM cell lines with either CAR T cells or untransduced T cells (Ctrl) at 1-to-1 effector-to-target (E: T) ratio for 5 days. This evidence concerns the gene CD276 and glioblastoma.